Nordea Investment Management AB Takes $1.91 Million Position in Sotera Health Company $SHC

Nordea Investment Management AB purchased a new position in Sotera Health Company (NASDAQ:SHC) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 107,822 shares of the company’s stock, valued at approximately $1,908,000.

Other institutional investors also recently added to or reduced their stakes in the company. Arizona State Retirement System grew its stake in Sotera Health by 1.4% in the third quarter. Arizona State Retirement System now owns 46,183 shares of the company’s stock valued at $726,000 after purchasing an additional 621 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Sotera Health by 31.1% during the fourth quarter. GAMMA Investing LLC now owns 4,892 shares of the company’s stock valued at $86,000 after buying an additional 1,161 shares during the last quarter. Legal & General Group Plc boosted its holdings in shares of Sotera Health by 0.5% in the 3rd quarter. Legal & General Group Plc now owns 255,526 shares of the company’s stock valued at $4,019,000 after buying an additional 1,252 shares in the last quarter. California State Teachers Retirement System grew its position in shares of Sotera Health by 0.9% in the 3rd quarter. California State Teachers Retirement System now owns 145,318 shares of the company’s stock worth $2,286,000 after buying an additional 1,315 shares during the last quarter. Finally, Versant Capital Management Inc grew its position in shares of Sotera Health by 117.6% in the 3rd quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock worth $40,000 after buying an additional 1,370 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Insiders Place Their Bets

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the transaction, the director directly owned 12,735,301 shares of the company’s stock, valued at approximately $194,468,046.27. This represents a 43.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 47.55% of the company’s stock.

Sotera Health Trading Down 3.0%

NASDAQ:SHC opened at $13.13 on Friday. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $19.85. The firm has a fifty day simple moving average of $16.28 and a 200-day simple moving average of $16.58. The company has a current ratio of 2.46, a quick ratio of 2.24 and a debt-to-equity ratio of 3.66. The company has a market capitalization of $3.73 billion, a P/E ratio of 48.63 and a beta of 1.84.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The firm had revenue of $303.44 million for the quarter, compared to the consensus estimate of $300.68 million. During the same period in the prior year, the firm earned $0.21 EPS. The firm’s revenue was up 4.6% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. On average, equities research analysts anticipate that Sotera Health Company will post 0.61 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Wells Fargo & Company lowered shares of Sotera Health to an “overweight” rating in a research note on Thursday, January 8th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th. Citigroup upped their price target on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Piper Sandler upgraded Sotera Health from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $17.00 to $24.00 in a report on Friday, January 9th. Finally, Zacks Research cut Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Sotera Health currently has an average rating of “Moderate Buy” and a consensus target price of $20.43.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.